INVA Message Board Post 9000482 | Innoviva Inc.
home / stock / inva / inva message board
mbweil
(investorshub)
Posted on: Sep/29/2014 22:54:07
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=106722976
Not always the case. Do some digging. You'll
News, Short Squeeze, Breakout and More Instantly...
-
2024-05-12 00:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
-
Core royalty platform on track; receiving GSK royalties of $61.9 million Achieved net product revenues of $19.1 million, representing 66% year-over-year growth driven by launch of XACDURO® and growth of key core product GIAPREZA® Strong pipeline progress: positive Phase ...
-
Innoviva, Inc. (NASDAQ: INVA) (“Innoviva” or the “Company”), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics (“IST”), and a portfolio of strate...